Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Turkel · SciRah

Researcher profile · Semantic Scholar

C. Turkel

Share profile

C. Turkel — researcher profile on SciRah

h-index: 33
Works: 72
Citations: 7,377

Most-cited papers

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program
D. Dodick, C. Turkel, R. Degryse, S. Aurora +4 more
2010Headache914 citations
Semantic Scholar
Global prevalence of chronic migraine: A systematic review
J. Natoli, Aubrey N. Manack, B. Dean, Q. Butler +3 more
2010Cephalalgia648 citations
Semantic Scholar
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
D. Buse, Aubrey N. Manack, D. Serrano, C. Turkel +1 more
2010Journal of Neurology Neurosurgery & Psychiatry570 citations Open access
Semantic Scholar
Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study
D. Buse, Aubrey N. Manack, K. Fanning, D. Serrano +3 more
2012Headache515 citations
Semantic Scholar
Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
A. Brashear, Mark F. Gordon, E. Elovic, V. D. Kassicieh +5 more
2002New England Journal of Medicine408 citations Open access
Semantic Scholar
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56‐Week PREEMPT Clinical Program
S. Aurora, P. Winner, Marshall C. Freeman, E. Spierings +5 more
2011Headache286 citations
Semantic Scholar
Depression and risk of transformation of episodic to chronic migraine
S. Ashina, D. Serrano, R. Lipton, M. Maizels +4 more
2012The Journal of Headache and Pain283 citations Open access
Semantic Scholar
Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity.
A. Brashear, R. Zafonte, M. Corcoran, N. Gálvez-Jiménez +8 more
2002Archives of Physical Medicine and Rehabilitation271 citations
Semantic Scholar
Botulinum Toxin Type A (BOTOX®) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial
N. Mathew, B. Frishberg, M. Gawel, R. Dimitrova +2 more
2005Headache268 citations
Semantic Scholar
Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well‐Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program
A. Blumenfeld, S. Silberstein, D. Dodick, S. Aurora +2 more
2010Headache238 citations
Semantic Scholar
Headache Impact of Chronic and Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study
D. Buse, Aubrey N. Manack, D. Serrano, M. Reed +3 more
2012Headache214 citations
Semantic Scholar
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
S. Silberstein, A. Blumenfeld, R. Cady, Ira M. Turner +7 more
2013Journal of Neurological Sciences208 citations
Semantic Scholar
Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.
M. Childers, A. Brashear, P. Jozefczyk, M. Reding +6 more
2004Archives of Physical Medicine and Rehabilitation200 citations
Semantic Scholar
Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
S. Silberstein, Stuart R. Stark, S. Lucas, S. Christie +2 more
2005Mayo Clinic proceedings184 citations
Semantic Scholar
OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program
S. Aurora, D. Dodick, Hans-Christoph Diener, R. Degryse +3 more
2013Acta Neurologica Scandinavica170 citations Open access
Semantic Scholar
Rates, predictors, and consequences of remission from chronic migraine to episodic migraine
Aubrey N. Manack, D. Buse, D. Serrano, C. Turkel +1 more
2011Neurology164 citations
Semantic Scholar
Botulinum Toxin Type A in the Prophylactic Treatment of Chronic Tension-Type Headache: A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study
S. Silberstein, H. Göbel, R. Jensen, A. Elkind +3 more
2006Cephalalgia163 citations Open access
Semantic Scholar
Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.
L. Koman, A. Brashear, S. Rosenfeld, H. Chambers +9 more
2001Pediatrics161 citations
Semantic Scholar
Prevalence and Burden of Chronic Migraine in Adolescents: Results of the Chronic Daily Headache in Adolescents Study (C‐dAS)
R. Lipton, Aubrey N. Manack, J. Ricci, E. Chee +2 more
2011Headache151 citations
Semantic Scholar
OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine
R. Lipton, S. Varon, B. Grosberg, P. McAllister +8 more
2011Neurology141 citations
Semantic Scholar
Relationship Between Disability and Health‐Related Quality of Life and Caregiver Burden in Patients With Upper Limb Poststroke Spasticity
Q. Doan, A. Brashear, P. Gillard, S. Varon +3 more
2012PM & R : the journal of injury, function, and rehabilitation139 citations
Semantic Scholar
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT
S. Silberstein, D. Dodick, S. Aurora, H. Diener +3 more
2014Journal of Neurology Neurosurgery & Psychiatry137 citations Open access
Semantic Scholar
Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
E. Elovic, A. Brashear, D. Kaelin, Jingyu Liu +3 more
2008Archives of Physical Medicine and Rehabilitation125 citations
Semantic Scholar
Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke
M. Gordon, A. Brashear, E. Elovic, D. Kassicieh +3 more
2004Neurology102 citations
Semantic Scholar
placebo-controlled phase of the PREEMPT 2 trial OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized,
H. Diener, D. Dodick, S. Aurora, C. Turkel +3 more
201191 citations
Semantic Scholar
Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
C. Turkel, B. Bowen, Jingyu Liu, M. Brin
2006Archives of Physical Medicine and Rehabilitation86 citations
Semantic Scholar
Chronic migraine: Classification and comparisons
Z. Katsarava, Aubrey N. Manack, M. Yoon, M. Obermann +5 more
2011Cephalalgia77 citations
Semantic Scholar
Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
S. Yablon, A. Brashear, M. Gordon, E. Elovic +4 more
2007Clinical Therapeutics71 citations
Semantic Scholar
Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example.
D. Dodick, C. Turkel, R. Degryse, H. Diener +4 more
2015Journal of Pain66 citations Open access
Semantic Scholar
Intra-articular onabotulinumtoxinA in osteoarthritis knee pain: effect on human mechanistic pain biomarkers and clinical pain
L. Arendt-Nielsen, G.-L. Jiang, R. Degryse, C. Turkel
2017Scandinavian Journal of Rheumatology53 citations
Semantic Scholar
Development of onabotulinumtoxinA for chronic migraine
S. Whitcup, C. Turkel, R. Degryse, Mitchell F. Brin
2014Annals of the New York Academy of Sciences53 citations Open access
Semantic Scholar
The Evolution of Chronic Migraine: Classification and Nomenclature
Aubrey N. Manack, C. Turkel, S. Silberstein
2009Headache43 citations
Semantic Scholar
Improving the Classification of Migraine Subtypes: An Empirical Approach Based on Factor Mixture Models in the American Migraine Prevalence and Prevention (AMPP) Study
R. Lipton, D. Serrano, Jelena M. Pavlović, Aubrey N. Manack +3 more
2014Headache38 citations
Semantic Scholar
Dichloroacetate: Population Pharmacokinetics with a Pharmacodynamic Sequential Link Model
Paul J. Williams, J. Lane, C. Turkel, E. Capparelli +2 more
2001Journal of clinical pharmacology19 citations
Semantic Scholar
Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impact
A. Esquenazi, W. Jost, C. Turkel, T. Wein +1 more
2023Medicine16 citations Open access
Semantic Scholar
MR spectroscopy study of dichloroacetate treatment after ischemic stroke
G. Graham, P. Barker, William M. Brooks, Daniel C. Morris +6 more
2000Neurology16 citations
Semantic Scholar
Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact
C. Turkel, S. Aurora, Hans-Christoph Diener, D. Dodick +3 more
2023Medicine13 citations Open access
Semantic Scholar
Dichloroacetate and cerebral ischaemia therapeutics.
P. Marangos, C. Turkel, Zofia E. Dziewanowska, A. Fox
1999Expert Opinion on Investigational Drugs11 citations
Semantic Scholar
The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program
S. Silberstein, D. Dodick, R. Degryse, Richard B. Lipton +1 more
2013The Journal of Headache and Pain9 citations Open access
Semantic Scholar
Role of Epidemiological Data Within the Drug Development Lifecycle: A Chronic Migraine Case Study
Aubrey N. Manack, C. Turkel, H. Kaplowitz
20128 citations Open access
Semantic Scholar
Results from a single center, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy and safety of intra-articular onabotulinumtoxina for osteoarthritis knee pain
K. Kalunian, L. Arendt-Nielsen, C. Turkel, R. Degryse +3 more
20146 citations Open access
Semantic Scholar
Female leaders' 360-degree self -perception accuracy for leadership competencies and skills
C. Turkel
20086 citations
Semantic Scholar
OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phase of the PREEMPT clinical program
D. Dodick, S. Aurora, C. Turkel, R. Degryse +4 more
20135 citations
Semantic Scholar
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
Hans-Christoph Diener, D. Dodick, R. Degryse, C. Turkel
2013The Journal of Headache and Pain4 citations Open access
Semantic Scholar
Developing Common Data Elements (CDEs) for headache clinical research: A National Institute of Neurological Disorders and Stroke (NINDS), NIH initiative
Brin Mitchell, A. Charles, S. Aurora, D. Borsook +41 more
20124 citations
Semantic Scholar
OnabotulinumtoxinA for Treatment of Chronic Migraine: 75% Responder Analysis Results from the Double-Blind, Randomized, Placebo-Controlled Phase of the PREEMPT Clinical Program (P03.227)
D. Dodick, H. Diener, C. Turkel, R. Degryse +1 more
20124 citations
Semantic Scholar
OnabotulinumtoxinA for Treatment of Chronic Migraine: A Response
D. Dodick, C. Turkel, R. Degryse, S. Aurora +4 more
2011Headache4 citations
Semantic Scholar
A single center, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy and safety of intra-articular onabotulinumtoxina as treatment for osteoarthritis knee pain: results from the experimental pain models
L. Arendt-Nielsen, G.-L. Jiang, R. Degryse, C. Turkel
20143 citations Open access
Semantic Scholar
OnabotulinumtoxinA for chronic migraine treatment: 75% responder analysis from double-blind, randomized, placebo-controlled phase of PREEMPT
D. Dodick, H. Diener, C. Turkel, R. Degryse +1 more
2013The Journal of Headache and Pain3 citations Open access
Semantic Scholar
OnabotulinumtoxinA for chronic migraine: PREEMPT trials establish a safe and effective dose and injection paradigm
A. Blumenfeld, S. Silberstein, D. Dodick, S. Aurora +2 more
20133 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Degryse×19
Invite
R. Degryse — researcher profile on SciRah
D. Dodick×16
Invite
D. Dodick — researcher profile on SciRah
S. Aurora×13
Invite
S. Aurora — researcher profile on SciRah
S. Silberstein×11
Invite
S. Silberstein — researcher profile on SciRah

Aubrey N. Manack

×9

Invite

Aubrey N. Manack — researcher profile on SciRah

Invite

R. Lipton — researcher profile on SciRah

Invite

H. Diener — researcher profile on SciRah

Invite

A. Brashear — researcher profile on SciRah

Invite

D. Buse — researcher profile on SciRah

Invite

D. Serrano — researcher profile on SciRah

Invite

M. Brin — researcher profile on SciRah

Invite

R. Lipton — researcher profile on SciRah